ArticleBMC urology2025
Laparoscopic pyeloplasty in infants with ureteropelvic junction obstruction managed with the enhanced recovery after surgery approach: a single-center experience.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo report our single-center experience of laparoscopic pyeloplasty for the treatment of ureteropelvic junction obstruction (UPJO) in infants managed with the Enhanced Recovery After Surgery (ERAS) approach.
methodsThe clinical data of infants aged ≤ 12 months with UPJO who underwent laparoscopic pyeloplasty at our center from October 2018 to October 2023 and who were eligible for inclusion according to the inclusion and exclusion criteria were collected. General clinical, perioperative, and postoperative data were collected. All infants were managed with the ERAS approach. ERAS is a multidisciplinary perioperative approach designed to improve perioperative management and facilitate patient early recovery.
resultsOverall, 37 patients were included. All surgeries were successfully completed without conversion to open surgery. The median age of the patients was 2 (1, 4.5) months. The median weight was 6.5 (5.25, 7.25) kg. The mean surgical duration was 251.3 ± 65.4 min, and the mean hemorrhage volume was 7.4 ± 5.3 mL. There were no intraoperative complications. The mean postoperative pain score was 0.24 ± 0.86, and the median urinary catheter removal time was 1 (1, 1) day. The mean postoperative hospital length of stay was 2.7 ± 2.3 days, and the mean overall hospital stay was 6.5 ± 3.5 days. The mean hospital cost was 31,515.2 ± 5,550.9 yuan. Postoperative complications were observed in 9 patients (24.3%), including one patient (2.7%) with intestinal obstruction (Clavien-Dindo classification grade I), four (10.8%) with febrile urinary tract infection (Clavien-Dindo classification grade II), and four (10.8%) with distal ureteral stricture. The median time to double J-tube extraction was 35 (32,66) days, the mean follow-up time was 33.6 (± 20.7) months, and the success rate was 100% (37 of 37 patients).
conclusionsERAS-managed laparoscopic pyeloplasty is safe and effective in infants with UPJO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.